[1]
“05 | Artificial intelligence for infectious risk assessment in the general population: methods, limits and the DARE (DIGIVAX) pilot”, EuroMed Bio J, vol. 21, no. s1, Nov. 2026, doi: 10.3269/g1grkt03.